

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA methylation involved in gamete generation (GO:0043046) | 4.40625235 |
| 2 | negative regulation of phagocytosis (GO:0050765) | 3.97927058 |
| 3 | piRNA metabolic process (GO:0034587) | 3.83326805 |
| 4 | positive regulation of granulocyte differentiation (GO:0030854) | 3.79787851 |
| 5 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.62428265 |
| 6 | respiratory chain complex IV assembly (GO:0008535) | 3.62282319 |
| 7 | peptidyl-histidine modification (GO:0018202) | 3.57078681 |
| 8 | synapsis (GO:0007129) | 3.47702489 |
| 9 | regulation of B cell apoptotic process (GO:0002902) | 3.45835150 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 3.25337984 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24991125 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24991125 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24991125 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.24991125 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24991125 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.24991125 |
| 17 | cytochrome complex assembly (GO:0017004) | 3.22416726 |
| 18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.18932720 |
| 19 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16776802 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.04390210 |
| 21 | kinetochore assembly (GO:0051382) | 2.98592052 |
| 22 | GPI anchor biosynthetic process (GO:0006506) | 2.95854001 |
| 23 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.93733008 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 2.81886653 |
| 25 | DNA deamination (GO:0045006) | 2.79776642 |
| 26 | branched-chain amino acid catabolic process (GO:0009083) | 2.78948831 |
| 27 | keratinocyte development (GO:0003334) | 2.78500634 |
| 28 | regulation of vacuole organization (GO:0044088) | 2.77465540 |
| 29 | kinetochore organization (GO:0051383) | 2.75384015 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73293590 |
| 31 | C-terminal protein lipidation (GO:0006501) | 2.70409957 |
| 32 | regulation of autophagic vacuole assembly (GO:2000785) | 2.70138215 |
| 33 | T cell homeostasis (GO:0043029) | 2.68269022 |
| 34 | GPI anchor metabolic process (GO:0006505) | 2.62313186 |
| 35 | inositol phosphate catabolic process (GO:0071545) | 2.61878694 |
| 36 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.60478867 |
| 37 | regulation of granulocyte differentiation (GO:0030852) | 2.58436570 |
| 38 | branched-chain amino acid metabolic process (GO:0009081) | 2.58360204 |
| 39 | protein import into peroxisome matrix (GO:0016558) | 2.56979968 |
| 40 | DNA synthesis involved in DNA repair (GO:0000731) | 2.54233034 |
| 41 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.53146844 |
| 42 | oxygen transport (GO:0015671) | 2.51115089 |
| 43 | histone H4-K16 acetylation (GO:0043984) | 2.48432382 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48112024 |
| 45 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.47522304 |
| 46 | response to peptidoglycan (GO:0032494) | 2.47365066 |
| 47 | resolution of meiotic recombination intermediates (GO:0000712) | 2.44779989 |
| 48 | male meiosis I (GO:0007141) | 2.42593106 |
| 49 | rRNA modification (GO:0000154) | 2.41958440 |
| 50 | ribosome assembly (GO:0042255) | 2.41868531 |
| 51 | definitive hemopoiesis (GO:0060216) | 2.38540305 |
| 52 | valine metabolic process (GO:0006573) | 2.37464610 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36928904 |
| 54 | erythrocyte maturation (GO:0043249) | 2.36619644 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34744705 |
| 56 | protein complex biogenesis (GO:0070271) | 2.32912300 |
| 57 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.32391916 |
| 58 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.31058598 |
| 59 | leukocyte degranulation (GO:0043299) | 2.28620159 |
| 60 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.27766883 |
| 61 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.26280620 |
| 62 | histone H2A acetylation (GO:0043968) | 2.25852139 |
| 63 | RNA methylation (GO:0001510) | 2.25360140 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23342342 |
| 65 | response to host immune response (GO:0052572) | 2.23342342 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.23303264 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.23303264 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 2.23303264 |
| 69 | megakaryocyte development (GO:0035855) | 2.22636272 |
| 70 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.22270074 |
| 71 | tRNA modification (GO:0006400) | 2.21423628 |
| 72 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.20199925 |
| 73 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.20199925 |
| 74 | tRNA methylation (GO:0030488) | 2.19989047 |
| 75 | regulation of histone H3-K4 methylation (GO:0051569) | 2.19657322 |
| 76 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.19275111 |
| 77 | inositol phosphate dephosphorylation (GO:0046855) | 2.19275111 |
| 78 | DNA catabolic process, endonucleolytic (GO:0000737) | 2.19176394 |
| 79 | regulation of gamma-delta T cell activation (GO:0046643) | 2.18349419 |
| 80 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.18111927 |
| 81 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.17225704 |
| 82 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.16961957 |
| 83 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.16961957 |
| 84 | polyol catabolic process (GO:0046174) | 2.16483436 |
| 85 | meiosis I (GO:0007127) | 2.14417005 |
| 86 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.14321005 |
| 87 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.13120274 |
| 88 | regulation of B cell differentiation (GO:0045577) | 2.11831462 |
| 89 | mast cell degranulation (GO:0043303) | 2.10321298 |
| 90 | mast cell activation involved in immune response (GO:0002279) | 2.10321298 |
| 91 | negative regulation of T cell apoptotic process (GO:0070233) | 2.09981828 |
| 92 | DNA double-strand break processing (GO:0000729) | 2.09669027 |
| 93 | negative regulation of translational initiation (GO:0045947) | 2.09183431 |
| 94 | negative regulation of B cell apoptotic process (GO:0002903) | 2.08859839 |
| 95 | negative regulation of cell size (GO:0045792) | 2.08081676 |
| 96 | negative regulation of stem cell proliferation (GO:2000647) | 2.08074688 |
| 97 | C-terminal protein amino acid modification (GO:0018410) | 2.07778542 |
| 98 | rRNA methylation (GO:0031167) | 2.07729217 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.07676217 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.06992677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.55752038 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12988275 |
| 3 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.75380258 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.75117005 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.67996813 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.66789958 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57435368 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.50631953 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.47839969 |
| 10 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.44544961 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.38164994 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22956100 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.20062271 |
| 14 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18209901 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.17973202 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11663720 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09824466 |
| 18 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.08122413 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.02132979 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01730075 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.01296147 |
| 22 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.98017456 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91350926 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89382297 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.83884536 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83569011 |
| 27 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83260200 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82251400 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82238019 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81386195 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74149004 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72571377 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71065680 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66543512 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.64902010 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.64467497 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64191220 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63704098 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63221127 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62364597 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59008616 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58493092 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.56937973 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56032824 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49009360 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48159208 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46191890 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45855671 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.42827340 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41051587 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40029134 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38064411 |
| 53 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37969936 |
| 54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37503645 |
| 55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37255227 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36396927 |
| 57 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32966826 |
| 58 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32020911 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31483126 |
| 60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31053741 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27932365 |
| 62 | * MYB_26560356_Chip-Seq_TH2_Human | 1.27859539 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27381487 |
| 64 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26408894 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26190622 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25179643 |
| 67 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22670376 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22254483 |
| 69 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21503925 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17208416 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15240651 |
| 72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.14577498 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14530972 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11999598 |
| 75 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09663879 |
| 76 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09461971 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08540033 |
| 78 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08314978 |
| 79 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.07891636 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07535214 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06751793 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04903906 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04855516 |
| 84 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04197709 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02220354 |
| 86 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01894131 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01882028 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01711672 |
| 89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99543789 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98922317 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97269151 |
| 92 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96088748 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95778191 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94007367 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93397342 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92075470 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91973798 |
| 98 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90578084 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88800955 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87487940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002132_abnormal_respiratory_system | 3.78906036 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.25701860 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.09071937 |
| 4 | MP0009697_abnormal_copulation | 2.81540584 |
| 5 | MP0008058_abnormal_DNA_repair | 2.63545900 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.40184225 |
| 7 | MP0003724_increased_susceptibility_to | 2.11103530 |
| 8 | MP0006035_abnormal_mitochondrial_morpho | 2.04677336 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 1.99503536 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 1.95941934 |
| 11 | MP0001661_extended_life_span | 1.94453546 |
| 12 | MP0010094_abnormal_chromosome_stability | 1.91011056 |
| 13 | MP0000685_abnormal_immune_system | 1.90646705 |
| 14 | MP0003172_abnormal_lysosome_physiology | 1.84701105 |
| 15 | MP0005365_abnormal_bile_salt | 1.74836103 |
| 16 | MP0008877_abnormal_DNA_methylation | 1.72576243 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.72026279 |
| 18 | MP0001764_abnormal_homeostasis | 1.71984516 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.70189639 |
| 20 | MP0000372_irregular_coat_pigmentation | 1.69575740 |
| 21 | MP0008995_early_reproductive_senescence | 1.69513383 |
| 22 | MP0005083_abnormal_biliary_tract | 1.67895700 |
| 23 | MP0005451_abnormal_body_composition | 1.67361826 |
| 24 | MP0002722_abnormal_immune_system | 1.56532124 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.55903292 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.55625311 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.55553223 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.55553223 |
| 29 | MP0000703_abnormal_thymus_morphology | 1.54506169 |
| 30 | MP0003786_premature_aging | 1.49597469 |
| 31 | MP0003436_decreased_susceptibility_to | 1.46309912 |
| 32 | MP0002160_abnormal_reproductive_system | 1.44727321 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.42282478 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.41916096 |
| 35 | MP0002398_abnormal_bone_marrow | 1.41765602 |
| 36 | MP0001800_abnormal_humoral_immune | 1.41462295 |
| 37 | MP0000516_abnormal_urinary_system | 1.40865878 |
| 38 | MP0005367_renal/urinary_system_phenotyp | 1.40865878 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.38065791 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.37038375 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.35662823 |
| 42 | MP0002419_abnormal_innate_immunity | 1.28612124 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 1.28289996 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.25950913 |
| 45 | MP0002723_abnormal_immune_serum | 1.23628007 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.23092678 |
| 47 | MP0001929_abnormal_gametogenesis | 1.20269581 |
| 48 | MP0003186_abnormal_redox_activity | 1.19772124 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.18237985 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18002640 |
| 51 | MP0005332_abnormal_amino_acid | 1.17405900 |
| 52 | MP0003195_calcinosis | 1.16111972 |
| 53 | MP0005025_abnormal_response_to | 1.15753769 |
| 54 | MP0001819_abnormal_immune_cell | 1.15682812 |
| 55 | MP0000716_abnormal_immune_system | 1.11922555 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.11878933 |
| 57 | MP0002429_abnormal_blood_cell | 1.09413562 |
| 58 | MP0008260_abnormal_autophagy | 1.09113141 |
| 59 | MP0004381_abnormal_hair_follicle | 1.08428843 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.08351964 |
| 61 | MP0003077_abnormal_cell_cycle | 1.05644270 |
| 62 | MP0001145_abnormal_male_reproductive | 1.05502200 |
| 63 | MP0010329_abnormal_lipoprotein_level | 1.05336500 |
| 64 | MP0002210_abnormal_sex_determination | 1.05181032 |
| 65 | MP0006054_spinal_hemorrhage | 1.04838989 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 1.04467316 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.02987032 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.02575432 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.01883612 |
| 70 | MP0001944_abnormal_pancreas_morphology | 0.99926955 |
| 71 | MP0002405_respiratory_system_inflammati | 0.99586531 |
| 72 | MP0000609_abnormal_liver_physiology | 0.98988646 |
| 73 | MP0005389_reproductive_system_phenotype | 0.98633523 |
| 74 | MP0009785_altered_susceptibility_to | 0.98536615 |
| 75 | MP0001790_abnormal_immune_system | 0.97512223 |
| 76 | MP0005387_immune_system_phenotype | 0.97512223 |
| 77 | MP0003698_abnormal_male_reproductive | 0.96488247 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.95914271 |
| 79 | MP0000653_abnormal_sex_gland | 0.95580693 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 0.95099149 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.94991256 |
| 82 | MP0000313_abnormal_cell_death | 0.94387623 |
| 83 | MP0008469_abnormal_protein_level | 0.94330399 |
| 84 | MP0000358_abnormal_cell_content/ | 0.94092306 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.93856573 |
| 86 | MP0003122_maternal_imprinting | 0.91926172 |
| 87 | MP0002139_abnormal_hepatobiliary_system | 0.91063328 |
| 88 | MP0000598_abnormal_liver_morphology | 0.90795074 |
| 89 | MP0005000_abnormal_immune_tolerance | 0.90209601 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.89247089 |
| 91 | MP0002127_abnormal_cardiovascular_syste | 0.89244169 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.85643397 |
| 93 | MP0008057_abnormal_DNA_replication | 0.85305401 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.85122831 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.79343256 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.78304019 |
| 97 | MP0009115_abnormal_fat_cell | 0.76643304 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.74581927 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.73782704 |
| 100 | MP0001984_abnormal_olfaction | 0.71771418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.31556027 |
| 2 | Cutaneous melanoma (HP:0012056) | 4.26204946 |
| 3 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.04334571 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 3.87736406 |
| 5 | Microvesicular hepatic steatosis (HP:0001414) | 3.39640956 |
| 6 | Squamous cell carcinoma (HP:0002860) | 3.26606292 |
| 7 | Abnormality of DNA repair (HP:0003254) | 3.12167442 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08884099 |
| 9 | Dyschromatopsia (HP:0007641) | 2.90043890 |
| 10 | Neoplasm of the adrenal cortex (HP:0100641) | 2.79591740 |
| 11 | Stomatitis (HP:0010280) | 2.71777909 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70666743 |
| 13 | Poikiloderma (HP:0001029) | 2.63099950 |
| 14 | Hepatocellular necrosis (HP:0001404) | 2.58130019 |
| 15 | Acute hepatic failure (HP:0006554) | 2.56726925 |
| 16 | Ketosis (HP:0001946) | 2.53732202 |
| 17 | Brushfield spots (HP:0001088) | 2.51194916 |
| 18 | Prolonged bleeding time (HP:0003010) | 2.50609649 |
| 19 | True hermaphroditism (HP:0010459) | 2.47374841 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.47371832 |
| 21 | Recurrent fungal infections (HP:0002841) | 2.41092186 |
| 22 | Reticulocytosis (HP:0001923) | 2.39751727 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 2.37896963 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.32279806 |
| 25 | Asymmetry of the thorax (HP:0001555) | 2.32225807 |
| 26 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31346962 |
| 27 | Cheilitis (HP:0100825) | 2.24592269 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24558487 |
| 29 | Basal cell carcinoma (HP:0002671) | 2.23665964 |
| 30 | Hepatic necrosis (HP:0002605) | 2.22896900 |
| 31 | Hypochromic anemia (HP:0001931) | 2.22590157 |
| 32 | Thyroiditis (HP:0100646) | 2.21973143 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 2.21225605 |
| 34 | Hypoplastic pelvis (HP:0008839) | 2.21175357 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18799270 |
| 36 | Reduced antithrombin III activity (HP:0001976) | 2.18684572 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.14863600 |
| 38 | Osteomalacia (HP:0002749) | 2.13791215 |
| 39 | Granulocytopenia (HP:0001913) | 2.13595744 |
| 40 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.05849470 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05043607 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05043607 |
| 43 | Easy fatigability (HP:0003388) | 2.04094706 |
| 44 | Episodic fever (HP:0001954) | 2.04052289 |
| 45 | Abnormal ciliary motility (HP:0012262) | 2.03743609 |
| 46 | Recurrent skin infections (HP:0001581) | 2.03324673 |
| 47 | Cholelithiasis (HP:0001081) | 1.99940455 |
| 48 | Muscle fiber atrophy (HP:0100295) | 1.98286912 |
| 49 | Poor suck (HP:0002033) | 1.93961037 |
| 50 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92687310 |
| 51 | Joint hemorrhage (HP:0005261) | 1.91883726 |
| 52 | Acute lymphatic leukemia (HP:0006721) | 1.90913663 |
| 53 | Abnormal gallbladder morphology (HP:0012437) | 1.90896731 |
| 54 | Spastic paraparesis (HP:0002313) | 1.90629715 |
| 55 | Increased CSF lactate (HP:0002490) | 1.89491580 |
| 56 | Obstructive lung disease (HP:0006536) | 1.88346444 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88346444 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88255153 |
| 59 | Absent thumb (HP:0009777) | 1.87622124 |
| 60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87365297 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87365297 |
| 62 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87107454 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 1.85301987 |
| 64 | Cholecystitis (HP:0001082) | 1.85301987 |
| 65 | Increased serum lactate (HP:0002151) | 1.85194080 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 1.84491331 |
| 67 | Mitochondrial inheritance (HP:0001427) | 1.84255437 |
| 68 | Fetal akinesia sequence (HP:0001989) | 1.83499418 |
| 69 | Ketoacidosis (HP:0001993) | 1.83376271 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83213952 |
| 71 | Microcytic anemia (HP:0001935) | 1.82965132 |
| 72 | Abnormality of reticulocytes (HP:0004312) | 1.80218926 |
| 73 | Pancreatic cysts (HP:0001737) | 1.79894261 |
| 74 | Large for gestational age (HP:0001520) | 1.78660526 |
| 75 | B lymphocytopenia (HP:0010976) | 1.78655655 |
| 76 | Gingival bleeding (HP:0000225) | 1.76654485 |
| 77 | Neutropenia (HP:0001875) | 1.76514075 |
| 78 | Abnormality of macrophages (HP:0004311) | 1.76067545 |
| 79 | Combined immunodeficiency (HP:0005387) | 1.75623380 |
| 80 | Abnormal sex determination (HP:0012244) | 1.74720275 |
| 81 | Sex reversal (HP:0012245) | 1.74720275 |
| 82 | Eosinophilia (HP:0001880) | 1.74526502 |
| 83 | Epiphyseal stippling (HP:0010655) | 1.73459484 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 1.72466609 |
| 85 | Intestinal atresia (HP:0011100) | 1.71211556 |
| 86 | Progressive macrocephaly (HP:0004481) | 1.70590135 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70588131 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 1.70588131 |
| 89 | Hyperammonemia (HP:0001987) | 1.70431344 |
| 90 | Type I transferrin isoform profile (HP:0003642) | 1.69030324 |
| 91 | Popliteal pterygium (HP:0009756) | 1.67786742 |
| 92 | Abnormal glycosylation (HP:0012345) | 1.67736518 |
| 93 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.67736518 |
| 94 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.67736518 |
| 95 | Abnormal protein glycosylation (HP:0012346) | 1.67736518 |
| 96 | Cutaneous photosensitivity (HP:0000992) | 1.66013820 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.65190154 |
| 98 | Myelodysplasia (HP:0002863) | 1.64844735 |
| 99 | Abnormality of B cell number (HP:0010975) | 1.64795629 |
| 100 | Hypoproteinemia (HP:0003075) | 1.64709679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.05345901 |
| 2 | PINK1 | 3.30292912 |
| 3 | MAP4K2 | 3.24968590 |
| 4 | EPHB1 | 3.06768935 |
| 5 | TRIM28 | 2.89956991 |
| 6 | TNK2 | 2.53995834 |
| 7 | MAP4K1 | 2.53442510 |
| 8 | FGFR2 | 2.29185211 |
| 9 | EIF2AK3 | 1.90109360 |
| 10 | MARK3 | 1.89308244 |
| 11 | STK16 | 1.79788099 |
| 12 | RIPK4 | 1.79174027 |
| 13 | DYRK3 | 1.68456090 |
| 14 | MAP2K3 | 1.63264394 |
| 15 | BCKDK | 1.61049515 |
| 16 | ERN1 | 1.58791513 |
| 17 | EIF2AK1 | 1.47314901 |
| 18 | IRAK4 | 1.41803815 |
| 19 | RAF1 | 1.41427496 |
| 20 | NME2 | 1.41108617 |
| 21 | FGFR3 | 1.36779013 |
| 22 | BRAF | 1.35930881 |
| 23 | BTK | 1.34552188 |
| 24 | NLK | 1.26651612 |
| 25 | TYK2 | 1.19768135 |
| 26 | ZAP70 | 1.15399584 |
| 27 | SMG1 | 1.15155679 |
| 28 | ZAK | 1.11205598 |
| 29 | PDK2 | 1.10858181 |
| 30 | BLK | 1.07361154 |
| 31 | CCNB1 | 1.06011944 |
| 32 | TLK1 | 1.05720679 |
| 33 | KSR2 | 1.05418114 |
| 34 | SYK | 1.00623402 |
| 35 | MST4 | 1.00239518 |
| 36 | CSNK1G3 | 0.98769102 |
| 37 | TAOK3 | 0.96592774 |
| 38 | MAP3K10 | 0.95742833 |
| 39 | WNK4 | 0.95719033 |
| 40 | CSNK1A1L | 0.93802044 |
| 41 | GRK6 | 0.93779880 |
| 42 | YES1 | 0.90726378 |
| 43 | PKN2 | 0.90615083 |
| 44 | KSR1 | 0.89533113 |
| 45 | TEC | 0.89113228 |
| 46 | SIK3 | 0.86838644 |
| 47 | NME1 | 0.85609787 |
| 48 | ATR | 0.85524449 |
| 49 | HCK | 0.85055415 |
| 50 | CDK7 | 0.83854721 |
| 51 | NUAK1 | 0.81881815 |
| 52 | LYN | 0.79853441 |
| 53 | CSNK1G1 | 0.79260159 |
| 54 | PIK3CG | 0.79246181 |
| 55 | PRKCI | 0.78406155 |
| 56 | CSF1R | 0.77840539 |
| 57 | GRK1 | 0.77446327 |
| 58 | IKBKE | 0.74024278 |
| 59 | ACVR1B | 0.73161087 |
| 60 | BCR | 0.72960648 |
| 61 | PTK2B | 0.70967332 |
| 62 | MAP3K1 | 0.70669662 |
| 63 | IKBKB | 0.70257787 |
| 64 | FGR | 0.70124318 |
| 65 | PRKCQ | 0.68776100 |
| 66 | PDK1 | 0.68491366 |
| 67 | HIPK2 | 0.67057072 |
| 68 | BMPR1B | 0.65718876 |
| 69 | PBK | 0.63079229 |
| 70 | BRSK2 | 0.62014160 |
| 71 | PDPK1 | 0.61919361 |
| 72 | RPS6KB1 | 0.60553906 |
| 73 | TBK1 | 0.57270827 |
| 74 | VRK2 | 0.55953354 |
| 75 | NEK2 | 0.55670699 |
| 76 | RPS6KA4 | 0.55354569 |
| 77 | FES | 0.55156516 |
| 78 | CAMKK2 | 0.55140190 |
| 79 | TNIK | 0.54700325 |
| 80 | MAP3K2 | 0.54131277 |
| 81 | MAPKAPK2 | 0.51443148 |
| 82 | IRAK2 | 0.50884073 |
| 83 | BRSK1 | 0.50401000 |
| 84 | CDK4 | 0.49559092 |
| 85 | VRK1 | 0.48664198 |
| 86 | RPS6KB2 | 0.47816526 |
| 87 | RET | 0.47231340 |
| 88 | MELK | 0.46201217 |
| 89 | PIM2 | 0.45036122 |
| 90 | MAP3K3 | 0.41320894 |
| 91 | MAP3K8 | 0.40817081 |
| 92 | JAK2 | 0.40053957 |
| 93 | RPS6KA5 | 0.39990953 |
| 94 | MAPK11 | 0.39472654 |
| 95 | ATM | 0.39042326 |
| 96 | DYRK2 | 0.37898556 |
| 97 | MKNK1 | 0.37354867 |
| 98 | LCK | 0.37198204 |
| 99 | ITK | 0.37181404 |
| 100 | CDC42BPA | 0.36387607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.69461169 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 2.80014769 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.57565633 |
| 4 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.51145394 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.44845304 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.34633010 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.25346249 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.06430884 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.96603783 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.95376582 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 1.84577379 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80566208 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.79447937 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.66058449 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55845823 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53444065 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52566757 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48379704 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41803571 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.41504271 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41061600 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37877269 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.36016299 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35207020 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31965920 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30371086 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29086309 |
| 28 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28749740 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26108664 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25058582 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22175105 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20270325 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18808686 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16261810 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.09593936 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05421984 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02680372 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.02455423 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00965627 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 0.97769536 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97416448 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95846831 |
| 43 | RNA transport_Homo sapiens_hsa03013 | 0.95019143 |
| 44 | Measles_Homo sapiens_hsa05162 | 0.93480193 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93118955 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91033266 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89723006 |
| 48 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86926913 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86682109 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85046314 |
| 51 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84965045 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 0.84841493 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84621674 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83787916 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.82443171 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82232831 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81962636 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79433558 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77248740 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75907080 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75246989 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74044353 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.72924352 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72185873 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.71189760 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70992208 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70335740 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68324475 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66306716 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65235494 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64617747 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64054823 |
| 73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63943180 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63172262 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60103715 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59428894 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58227213 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57929567 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57201931 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56990198 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55555797 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54100021 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52370486 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51342657 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51150163 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50869644 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.50652908 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49743634 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.49477531 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.47716496 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46961557 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46581026 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46460847 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.45624181 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45509304 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45090807 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43001992 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42307086 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40435578 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39182826 |

